Filter by
Filter by
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Published in JAMA Network Open, this retrospective study included 292 patients with nonmetastatic oropharyngeal cancer (OPC) of which 272 [93%] were HPV...
Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability.
This study reported outcomes of 15 patients with T1-2N0 glottic cancer treated to a total dose 70 Gy. The one- and two-year OS and metastases-free survival were...
Proton Arc Therapy
Proton Arc Therapy has the potential to improve dose conformity to the tumor while further reducing dose to the adjacent surrounding healthy tissue and...
Proton and Carbon Ion Radiotherapy Decreased Severe Lymphopenia by Reducing Thoracic Vertebra and Aortic Dose in Non-small Cell Lung Cancer versus Intensity Modulated Radiotherapy.
Published in the Red Journal, this study reported lymphopenia differences between IMRT and proton/carbon ion (PCIRT) for NSCLC. With data of 343 patients, this...
Early Toxicity and Patient-Reported Cosmetic Outcomes in Patients Treated With Adjuvant Proton-Based Radiotherapy After Breast-Conserving Surgery.
This study reported early toxicity and cosmetic outcomes of 21 patients treated with breast-conserving surgery and adjuvant PBT. Grade 2 and 3 dermatitis...